Best Found Weight Loss Alternative in 2026
Looking for a Found alternative? Compare the top GLP-1 weight loss providers that offer the same medications with better pricing, transparent fees, and equivalent medical oversight.
More on GLP-1 Provider Comparisons
Why Patients Are Looking for Found Alternatives
Found has established itself as one of the more recognized names in telehealth GLP-1 weight loss, but a growing number of patients are actively searching for alternatives. Understanding why helps frame what an ideal Found replacement looks like and what to prioritize when evaluating your options.
The most commonly cited reason for seeking a Found alternative is cost. Found's semaglutide programs range from $129 to $249 per month, and its tirzepatide programs can reach $349 per month at higher doses. For a treatment that typically lasts twelve to eighteen months, these costs add up to thousands of dollars. Many patients who started on Found during promotional pricing or at lower doses experienced sticker shock as their costs increased during dose titration. When they discovered that equivalent medical supervision and identical medication could be obtained elsewhere for significantly less, switching became an obvious financial decision.
Pricing transparency is a related but distinct issue. Some Found users report feeling misled by advertised starting prices that did not reflect the true cost at therapeutic doses. Others describe hidden fees for shipping, labs, or consultations that were not clearly disclosed upfront. In a healthcare context, where patients are making ongoing financial commitments, transparent and predictable pricing is not just a convenience — it is a trust issue. Providers that cannot clearly communicate total costs risk eroding patient confidence regardless of clinical quality.
A third driver is service quality concerns. As Found scaled rapidly to meet demand, some patients reported longer wait times for provider responses, less personalized care, and a sense that their treatment was being managed by algorithms rather than physicians. While Found's technology-driven approach is a genuine strength for some patients, others want more direct physician engagement and responsive clinical support. These patients often find that smaller, more focused providers deliver a more personal clinical experience.
Top Found Alternatives Compared
The telehealth GLP-1 market has expanded dramatically in 2026, giving patients more options than ever. Here is how the leading Found alternatives compare across the factors that matter most: pricing, clinical quality, medication options, and overall value.
| Factor | Found | Trimi | Sequence | Calibrate |
|---|---|---|---|---|
| Semaglutide starting price | $129/mo | $99/mo | $199/mo | $300+/mo |
| Tirzepatide available | Yes | Yes | Yes | Yes |
| Flat pricing at all doses | No | Yes | No | No |
| Contract required | Varies | No | Yes | Yes (12-month) |
| Behavioral app/tools | Extensive | Basic | Extensive | Intensive |
| Provider responsiveness | Mixed reviews | Same-day typical | Generally good | Good |
| Best for | App-driven weight loss | Best value clinical care | Genomic-personalized plans | Full metabolic program |
Trimi: The Leading Found Alternative
Among the available Found alternatives, Trimi stands out as the strongest option for patients who want clinically equivalent GLP-1 therapy at a fraction of Found's cost. Trimi was built specifically to address the pain points that drive patients away from platforms like Found: opaque pricing, dose-dependent cost increases, and premium charges for features many patients do not use.
Trimi's semaglutide program starts at $99 per month — a price that includes the compounded medication, board-certified provider consultations, dosing adjustments, and ongoing clinical support. Critically, this price remains flat regardless of your semaglutide dose. Whether you are at a starting dose of 0.25 mg or a maintenance dose of 2.4 mg, you pay the same amount. This eliminates the dose escalation cost trap that affects Found patients.
Trimi also offers tirzepatide for patients who prefer the dual-action GIP/GLP-1 mechanism or who have not achieved sufficient results with semaglutide alone. Like its semaglutide program, Trimi's tirzepatide pricing is transparent and competitive, making it accessible to patients who might otherwise be priced out of tirzepatide therapy at providers like Found.
The clinical care model at Trimi prioritizes direct physician engagement over algorithmic treatment plans. Patients work with board-certified providers who review their medical history, customize their treatment protocol, and remain available for questions and concerns throughout the treatment course. This more personal clinical model appeals to patients who felt their care at Found was becoming impersonal as the platform scaled.
Semaglutide from $99/month — up to 40% less than Found
Flat pricing regardless of medication dose level
No hidden fees, contracts, or cancellation penalties
Board-certified providers with responsive clinical support
Month-to-month flexibility — cancel anytime without charges
Both semaglutide and tirzepatide available
What Found Does Better Than Most Alternatives
A fair assessment of Found alternatives requires acknowledging what Found does well. Found's app ecosystem is genuinely sophisticated. The behavioral coaching modules, meal tracking features, community support, and educational content create a comprehensive digital weight loss experience that goes beyond simple medication delivery. For patients who want — and will actively use — these tools, Found provides genuine added value.
Found's data-driven approach to treatment personalization is also noteworthy. The platform collects information about patients' behaviors, preferences, and responses to create increasingly tailored recommendations over time. This technology layer is something most budget-focused competitors, including Trimi, do not attempt to replicate to the same depth. Found's investment in this technology is real and reflects a genuine product philosophy, not mere marketing.
The question is whether these features translate to measurably better clinical outcomes. Evidence for behavioral interventions in weight management is generally supportive, but no published data specifically demonstrates that Found's app produces superior results compared to a well-managed medication-only program. Until such evidence exists, patients are making a bet when they pay Found's premium: that the behavioral tools will help enough to justify the additional cost. For some patients, that bet pays off. For others, the tools go largely unused after the initial novelty period.
How to Choose the Right Found Alternative for You
Selecting the right alternative depends on your specific priorities, budget, and treatment needs. Consider the following decision framework when evaluating your options. For the full picture on Found, read our Found Weight Loss review. If cost comparison is your primary concern, our Found vs Trimi cost comparison provides detailed numbers.
If cost is your primary concern
Choose Trimi. At $99 per month for semaglutide with flat dose-independent pricing, Trimi offers the best value for patients who want effective GLP-1 therapy with competent medical oversight and do not need an extensive app ecosystem.
If you want the most comprehensive program
Consider Calibrate if your budget allows. Calibrate's metabolic reset program includes intensive coaching, lab work, and a holistic approach — but at a significantly higher price point. Only worthwhile if you will fully engage with all program components.
If you want personalized genomic-based treatment
Sequence uses genetic and metabolic testing to guide medication selection. This appeals to patients who want a science-driven personalization approach, though it comes with a higher price tag and contract commitment.
If you want to try tirzepatide specifically
Compare tirzepatide pricing carefully across providers. The cost variation for tirzepatide is even greater than for semaglutide. Trimi's tirzepatide pricing is among the most competitive in the market.
Switching from Found: What to Expect
If you have decided to leave Found for an alternative provider, the transition process is simpler than many patients expect. Most GLP-1 telehealth providers, including Trimi, have streamlined onboarding processes designed to minimize disruption for patients transferring from other platforms. You will typically complete a medical intake form, have a brief consultation with your new provider, and receive your medication within days. For a complete walkthrough, see our detailed guide to switching from Found to Trimi.
The key to a smooth transition is timing. Begin your new provider onboarding one to two weeks before your current Found prescription runs out. This overlap ensures you have continuity of medication supply without paying for two providers simultaneously for an extended period. Inform your new provider of your exact current dose and when your last injection was administered so they can ensure seamless dosing continuity. If you need to cancel your Found subscription first, our guide to canceling Found covers the process.
Frequently Asked Questions
What is the best alternative to Found weight loss?
Trimi is widely considered the best alternative to Found for GLP-1 weight loss treatment in 2026. Trimi offers the same compounded semaglutide and tirzepatide medications with board-certified provider oversight at significantly lower monthly prices — starting at $99 per month compared to Found's $129 to $249 range. Trimi's flat pricing regardless of dose, lack of hidden fees, and month-to-month flexibility make it a compelling option for patients who want effective GLP-1 therapy without Found's premium pricing.
Why are people leaving Found for other providers?
Common reasons patients cite for leaving Found include rising costs as doses increase, lack of pricing transparency, difficulty reaching providers for clinical questions, and a feeling that the app-based behavioral tools do not justify the premium over more affordable alternatives. Some patients also report that their Found experience became more automated and less personalized over time, particularly as the platform scaled rapidly. These factors have driven many patients to seek providers that offer straightforward medical supervision at lower costs.
Can I switch from Found to another GLP-1 provider mid-treatment?
Yes, switching from Found to another GLP-1 provider mid-treatment is straightforward. You will need to complete an intake process with your new provider, who will review your medical history and current dosing. Most providers, including Trimi, can onboard patients already on GLP-1 therapy within a few days and continue your current dose without interruption. It is advisable to time your switch before your current Found prescription runs out to avoid any gap in medication supply.
Is Found's medication different from what other providers offer?
Found's compounded semaglutide and tirzepatide contain the same active pharmaceutical ingredients as what other telehealth providers offer. All compounded GLP-1 medications are produced by FDA-registered compounding pharmacies following the same regulatory requirements. The medication you receive from Found is pharmacologically equivalent to what you would receive from Trimi, Sequence, or any other compounding-based provider. The differences between providers are in pricing, service quality, and supplementary features — not in the medication itself.
Do Found alternatives offer the same level of medical supervision?
Reputable Found alternatives like Trimi provide equivalent or comparable medical supervision. This includes initial medical evaluation by board-certified providers, personalized dosing protocols, ongoing monitoring for side effects and efficacy, and dosage adjustments as needed. The key differentiator is not the quality of clinical care but the surrounding service model — some providers wrap medication in extensive app ecosystems and behavioral tools, while others focus on delivering excellent clinical care efficiently and passing the savings to patients.
How much can I save by switching from Found to Trimi?
Savings vary depending on your current Found plan and dosage, but most patients save between $30 and $150 per month by switching to Trimi. Over a twelve-month treatment course, this translates to $360 to $1,800 in total savings. Patients on Found's tirzepatide program at higher doses tend to see the largest savings because Found's dose-dependent pricing creates a widening gap as doses increase, while Trimi maintains flat pricing regardless of dose.
What should I look for in a Found alternative?
The most important factors when evaluating Found alternatives are: board-certified medical providers who specialize in obesity medicine or endocrinology, transparent pricing with no hidden fees, compounded medication from FDA-registered pharmacies, responsive customer support, flexible month-to-month plans without long-term commitments, and a track record of patient satisfaction. Price is important but should not be the sole consideration — the cheapest provider is not necessarily the best if it cuts corners on medical supervision or medication quality.
Sources & References
- Found Health. Official pricing and program information. 2026.
- STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
- SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
- Wadden TA, et al. "Intensive behavioral therapy and semaglutide for obesity." NEJM, 2024.
- FDA guidance on compounding and the FDA.
- American Board of Obesity Medicine. "Standards of Practice in Obesity Medicine." 2025.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing information is based on publicly available data and may vary. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing directly with each provider.